HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Salvatore Salomone Selected Research

Glucocorticoids

1/2020Effects of protein-protein interface disruptors at the ligand of the glucocorticoid-induced tumor necrosis factor receptor-related gene (GITR).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Salvatore Salomone Research Topics

Disease

12Inflammation (Inflammations)
10/2019 - 05/2008
9Diabetic Retinopathy (Retinopathy, Diabetic)
10/2020 - 07/2012
7Alzheimer Disease (Alzheimer's Disease)
01/2021 - 04/2012
6Schizophrenia (Dementia Praecox)
01/2021 - 01/2017
4Cognitive Dysfunction
01/2021 - 01/2017
4Neoplasms (Cancer)
01/2018 - 03/2013
4Macular Degeneration (Age-Related Maculopathy)
09/2017 - 01/2015
4Type 2 Diabetes Mellitus (MODY)
02/2013 - 01/2011
3Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 03/2013
3Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
05/2021 - 01/2019
3Memory Disorders (Memory Loss)
01/2021 - 04/2016
3Glaucoma
01/2015 - 02/2013
3Stroke (Strokes)
12/2008 - 05/2007
3Ulcer
08/2003 - 06/2002
2COVID-19
01/2021 - 01/2020
2Hyperglycemia
10/2020 - 10/2019
2Neurobehavioral Manifestations
01/2020 - 01/2016
2Drug-Related Side Effects and Adverse Reactions
01/2018 - 11/2012
2Retinal Diseases
01/2018 - 01/2015
2Hypoxia (Hypoxemia)
01/2016 - 05/2007
2Ocular Hypertension (Glaucoma, Suspect)
11/2013 - 02/2013
2Migraine Disorders (Migraine)
10/2009 - 01/2004
2Brain Ischemia (Cerebral Ischemia)
05/2008 - 05/2007
2Stomach Ulcer (Gastric Ulcer)
08/2003 - 01/2003
1Multiple Sclerosis
01/2022
1Wounds and Injuries (Trauma)
05/2021
1Paralysis (Palsy)
01/2021
1Parkinson Disease (Parkinson's Disease)
01/2020
1Oculocutaneous Albinism (Albinism, Yellow Mutant)
01/2020
1Rheumatoid Arthritis
01/2020
1Retinal Detachment (Retinal Detachments)
01/2020
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2020
1Proliferative Vitreoretinopathy
01/2020
1Crohn Disease (Crohn's Disease)
01/2020
1Hermanski-Pudlak Syndrome (Hermansky-Pudlak Syndrome)
01/2020
1Psychotic Disorders (Schizoaffective Disorder)
01/2020
1Rare Diseases (Rare Disease)
01/2020
1Autoimmune Diseases (Autoimmune Disease)
01/2020
1Macular Edema
10/2019
1Fibrosis (Cirrhosis)
12/2018
1Myasthenia Gravis
02/2018

Drug/Important Bio-Agent (IBA)

14Pharmaceutical PreparationsIBA
01/2022 - 04/2012
10Retinaldehyde (Retinal)IBA
10/2020 - 07/2012
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2020 - 12/2013
5Amyloid (Amyloid Fibrils)IBA
01/2021 - 02/2014
5Glucose (Dextrose)FDA LinkGeneric
10/2020 - 12/2013
4MicroRNAs (MicroRNA)IBA
05/2021 - 01/2015
4Dopamine (Intropin)FDA LinkGeneric
01/2021 - 11/2013
4Antipsychotic Agents (Antipsychotics)IBA
11/2020 - 01/2017
4Biomarkers (Surrogate Marker)IBA
01/2020 - 02/2014
3Antidepressive Agents (Antidepressants)IBA
01/2021 - 01/2016
3CannabidiolIBA
01/2021 - 01/2019
3ThiazolidinedionesIBA
02/2013 - 01/2011
3AdrenomedullinIBA
08/2003 - 06/2002
2AntioxidantsIBA
01/2021 - 01/2018
2Fluoxetine (Prozac)FDA LinkGeneric
01/2021 - 01/2019
2VortioxetineIBA
01/2021 - 01/2019
2Messenger RNA (mRNA)IBA
01/2021 - 01/2020
2CannabinoidsIBA
01/2021 - 01/2019
2Phospholipases A2 (Phospholipase A2)IBA
10/2020 - 12/2013
2Dopamine D3 ReceptorsIBA
01/2020 - 01/2017
2Methylazoxymethanol AcetateIBA
01/2020 - 01/2019
2afliberceptIBA
10/2019 - 01/2015
2Purinergic P2X7 ReceptorsIBA
10/2019 - 01/2017
2SteroidsIBA
12/2018 - 11/2013
2Biological ProductsIBA
12/2018 - 01/2018
2Antineoplastic Agents (Antineoplastics)IBA
01/2018 - 04/2016
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
11/2017 - 04/2015
2Buspirone (Buspar)FDA LinkGeneric
01/2017 - 07/2014
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
04/2015 - 07/2014
2HomocysteineIBA
01/2015 - 01/2014
2LigandsIBA
11/2013 - 06/2012
2rho-Associated KinasesIBA
12/2008 - 05/2007
2Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
08/2008 - 05/2007
1Sphingosine-1-Phosphate ReceptorsIBA
01/2022
1Immunologic Factors (Immunomodulators)IBA
01/2022
1Brain-Derived Neurotrophic Factor (BDNF)IBA
05/2021
1Paroxetine (Paxil)FDA LinkGeneric
05/2021
1Opioid Analgesics (Opioids)IBA
01/2021
1pimavanserinIBA
01/2020
1DysbindinIBA
01/2020
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
01/2020
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020
1Retinal Pigments (Pigments, Visual)IBA
01/2020
1VaccinesIBA
01/2020
1GlucocorticoidsIBA
01/2020
1brexpiprazoleIBA
01/2020
1Antimitotic AgentsIBA
01/2019
1Proteins (Proteins, Gene)FDA Link
01/2019
1AM 251 (AM251)IBA
01/2019
1CB1 Cannabinoid Receptor (CB1 Receptor)IBA
01/2019
1Haloperidol (Haldol)FDA LinkGeneric
01/2019
1SynaptophysinIBA
01/2019
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
12/2018
1Neostigmine (Neostigmine Bromide)IBA
02/2018

Therapy/Procedure

5Therapeutics
01/2018 - 05/2003
4Drug Therapy (Chemotherapy)
01/2019 - 05/2012
2Precision Medicine
11/2020 - 01/2020
1Conduction Anesthesia (Regional Anesthesia)
01/2021
1Drug Prescriptions
01/2018